Healthcare
Takeda Pharmaceutical Company Limited (TAK)
46/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $49.4B
- P/E
- 42.1
- Sector Median P/E
- 24.4
- F-Score
- 6/9
- ROIC
- 0.2%
- FCF Yield
- 9.5%
With a Tessera Quality Score of 45, TAK ranks in the top 50% of Healthcare stocks tracked. The stock's P/E of 42.1 sits 73% above the sector median of 24.4. Piotroski F-Score is 6/9; trailing ROIC is 0.2%.
Sector Peers
- Haleon plc (HLN)Mkt Cap: $39.6B · FCF: 11.9%
- Teva Pharmaceutical Industries Limited (TEVA)Mkt Cap: $36.7B · FCF: 6.8%
- Viatris Inc. (VTRS)Mkt Cap: $17.9B · FCF: 11.7%
- Intra-Cellular Therapies, Inc. (ITCI)Mkt Cap: $14.0B · FCF: -10.8%
- Elanco Animal Health Incorporated (ELAN)Mkt Cap: $12.1B · FCF: 6.4%